×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

Return to Previous Page
4012340

Availability: In stock

Boc-Phe-Ser-Arg-AMC acetate salt

4012340

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4012340.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 105.00
CHF 97.65 (7%)
4012340.0025 25 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 420.00
CHF 390.60 (7%)

Details

The fluorogenic substrate Boc-FSR-AMC is preferentially hydrolyzed by coagulation factor XIa. Boc-FSR-AMC is also highly susceptible to the proteases in yeast mitochondrial matrix as well as to tryptase from rat mast cells. In addition, the substrate is cleaved by acrosin from the ascidian Halocynthia roretzi. Stock solutions of Boc-FSR-AMC are best prepared in DMSO.
Catalog Number I-1400
One Letter Code Boc-FSR-AMC
Molecular Formula C₃₃H₄₃N₇O₈
Relative Molecular Mass 665.75
CAS Registry Number 73554-90-2
Source Synthetic
Storage Conditions -20 ± 5 °C
Application Hematology
Links / Documents:

Bachem product citations

S.J.Middendorp et al., J. Med. Chem., 60, 1151 (2017)
A.Di Nardo et al., J. Am. Acad. Dermatol., 74, 1086 (2016)
S.G.Danby et al., Br. J. Dermatol., 175, 1011 (2016)
T.C.Assumpcao et al., PLoS Negl. Trop. Dis., 10, e0004298 (2016)
J.J.Valdes et al., PLoS One, 8, e62562 (2013)
V.Baeriswyl et al., J. Med. Chem., 56, 3742 (2013)
G.Liang et al., ACS Med. Chem. Lett., 3, 159 (2012)
G.Liang et al., Bioorg. Med. Chem. Lett., 22, 2450 (2012)
M.D.Duong-Thi et al., Anal. Biochem., 414, 138 (2011)
I.M.Francischetti et al., PLoS One, 5, e9356 (2010)
N.Komatsu et al., J. Invest. Dermatol., 128, 1148 (2008)
C.V.Obiezu et al., Biol. Chem., 387, 749 (2006)
C.Kapadia et al., Clin. Chim. Acta, 339, 157 (2004)
M.C.Ghosh et al., Tumour Biol., 25, 193 (2004)
M.C.Ghosh et al., Tumour Biol., 25, 193 (2004)
A.Magklara et al., Biochem. Biophys. Res. Commun., 307, 948 (2003)
G.M.Yousef et al., Biochim. Biophys. Acta, 1628, 88 (2003)
T.Moreau et al., J. Biol. Chem., 267, 10045 (1992)

Product citations

M.Muramatu et al., Biol. Chem. Hoppe-Seyler, 369, 617 (1988)
T.Yasuhara and A.Ohashi, Biochem. Biophys. Res. Commun., 144, 277 (1987)
H.Sawada et al., J. Biol. Chem., 259, 2900 (1984)

4012340

Enzyme Substrates Inhibitors
Coagulation Factor XIa    
Tryptase